Cardiac Wire #355 April 2, 2026
Top Trends and Research from ACC.26
Cardiac Wire #354 March 30, 2026
A Strategy for CAD, BSCI’s Batteries, and Image-Guided Procedures
Cardiac Wire #353 March 26, 2026
Fatty Hearts, OmniaSecure’s Approval, and ALARA+
Cardiac Wire #352 March 23, 2026
Premature Menopause, Triple G Agonists, and CV Care Costs
Cardiac Wire #351 March 19, 2026
Ultraprocessed CVD, Lipid Guidelines, and Antidepressants’ SCD Risk
Cardiac Wire #350 March 16, 2026
JACC’s CV Report, Ablation in ASCs, and Top Research News
Cardiac Wire #349 March 12, 2026
IVI for PCI, Suspended Lead Suits, and Shockwave’s New IVL
Cardiac Wire #348 March 9, 2026
Barostim’s Results, BBs Bad for nHCM, and NORM’s New Results
Cardiac Wire #347 March 5, 2026
NT-proBNP for TEER, Protecting the Heart During Chemo, and THT News
Cardiac Wire #346 March 2, 2026
Cardiac Troponins Matter, The Pig in Our Hearts, and Pharma Business
Cardiac Wire #345 February 26, 2026
Women’s CVD Surge, Gut-Brain-Heart, and CV Imaging Radiation
Cardiac Wire #344 February 23, 2026
Market Drives TAVR, New PE Guidelines, and Cancer-CVD Research
Cardiac Wire #343 February 19, 2026
TAVR Reinterventions, Wearable Ultrasound, and Danaher Acquires Masimo
Cardiac Wire #342 February 16, 2026
DAPT in Diabetic CAD, HoFH’s Gender Differences, and University News
Cardiac Wire #341 February 12, 2026
Google’s AI in Cardiology, Chinese MedTech Espionage, and PFA News
Cardiac Wire #340 February 9, 2026
Statin Side Effects, BIOTRONIK’s FIH, and SCAI Backs ADP
Cardiac Wire #339 February 5, 2026
Medtronic Buys CathWorks, Top 50 Cardio-Hospitals, and AI Clearances
Cardiac Wire #338 February 2, 2026
Potential CKM Patients, REUP for Hearts, and Quadruple HF Meds
Cardiac Wire #337 January 29, 2026